In these KRAS-dependent colon cancer cells, KRAS activates bone morphogenetic protein 7 (BMP-7) signaling, leading to TAK1 activation, β-catenin nuclear localization and transcriptional upregulation of Wnt target genes [130]. This evidence concerns the gene KRAS and colonic neoplasm.